Overview

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
Long-term tacrolimus ointment based regimen comprising of up to 6 weeks of initial twice daily treatment and subsequent twice weekly prophylactic application can effectively treat active lesions of atopic dermatitis and prevent delay & reduce flares
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Tacrolimus